US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Maze Therapeutics

32.91

-0.3100-0.93%

Post-market: 32.910.00000.00%17:32 EDT

Volume:176.92K

Turnover:5.84M

Market Cap:1.57B

PE:-8.63

High:33.91

Open:33.51

Low:32.33

Close:33.22

52wk High:34.29

52wk Low:6.71

Shares:47.85M

Float Shares:20.43M

Volume Ratio:0.63

T/O Rate:0.87%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.8154

EPS(LYR):1.42

ROE:-62.95%

ROA:-30.29%

PB:6.01

PE(LYR):23.16

Loading ...

Overview Company News Filings

Maze Therapeutics files to sell 9.23M shares of common stock for holders

Maze Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Herve Hoppenot

Maze Therapeutics appoints Herve Hoppenot as chairman of the board

Press Release: Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors

Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), I-MAB (IMAB) and Cidara Therapeutics (CDTX)

Analysts’ Top Healthcare Picks: Maze Therapeutics, Inc. (MAZE), Repligen (RGEN)

Maze Therapeutics Is Maintained at Overweight by JP Morgan

U.S. RESEARCH ROUNDUP-Amazon, Insulet, Vertex

Maze Therapeutics Inc : JP Morgan Raises Target Price to $37 From $27

THOMSON REUTERS

Maze Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Two new option listings on September 17th

Maze Therapeutics Is Maintained at Buy by Guggenheim

Wedbush Boosts Price Target on Maze Therapeutics to $35 From $17, Keeps Outperform Rating

MT Newswires Live

Maze Therapeutics Is Maintained at Buy by BTIG

Maze Therapeutics Inc : Leerink Partners Raises Target Price to $34 From $28

THOMSON REUTERS

Maze Therapeutics Advances Clinical Programs Amid Financial Stability

Maze Therapeutics price target raised to $37 from $30 at BTIG

Maze Therapeutics price target raised to $34 from $28 at Leerink

BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus

Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday

Benzinga_recent_news

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAZE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":32.91,"timestamp":1761940800000,"preClose":33.22,"halted":0,"volume":176922,"hourTrading":{"tag":"盘后","latestPrice":32.91,"preClose":32.91,"latestTime":"17:32 EDT","volume":12212,"amount":401896.92,"timestamp":1761946357288},"delay":0,"floatShares":20434300,"shares":47850886,"eps":-3.815412,"marketStatus":"Market Closed","change":-0.31,"latestTime":"10-31 16:00:00 EDT","open":33.51,"high":33.91,"low":32.33,"amount":5836131.32166,"amplitude":0.047562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.815412,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":33.22,"postHourTrading":{"tag":"盘后","latestPrice":32.91,"preClose":32.91,"latestTime":"17:32 EDT","volume":12212,"amount":401896.92,"timestamp":1761946357288},"volumeRatio":0.6283500134717277,"impliedVol":0.5271,"impliedVolPercentile":0.4242},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":20434300,"roa":"-30.29%","roe":"-62.95%","lyrEps":1.421062,"volumeRatio":0.6283500134717277,"shares":47850886,"dividePrice":0,"high":33.91,"amplitude":0.047562,"preClose":33.22,"low":32.33,"week52Low":6.71,"pbRate":"6.01","psRate":"629.91","week52High":34.29,"institutionHeld":0,"latestPrice":32.91,"eps":-3.815412,"divideRate":0,"volume":176922,"delay":0,"ttmEps":-3.815412,"open":33.51,"prevYearClose":16,"prevWeekClose":30.39,"prevMonthClose":32.91,"prevQuarterClose":25.93,"fiveDayClose":30.39,"twentyDayClose":27.11,"sixtyDayClose":13.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"MAZE","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.77},{"market":"US","date":"2025-05-14","symbol":"MAZE","fiscalQuarterEnding":"2025/03","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.15},{"market":"US","date":"2025-03-31","symbol":"MAZE","fiscalQuarterEnding":"2024/12","expectedEps":-7.6,"name":null,"time":"","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"","actualEps":-18.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.4286,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5714,"analysts":7,"updateTime":1756872000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2025-10-31","current":-8.625543,"percent":0,"low":-12.059392,"twenty":-5.764695,"median":8.710535,"eighty":10.776638,"high":14.99285,"avg":4.514085,"sd":8.547142,"marketCap":1456726366},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746},{"date":"2025-04-25","current":6.456504,"twenty":7.783022,"median":9.224877,"eighty":9.897831,"marketCap":337229638},{"date":"2025-05-02","current":8.879789,"twenty":7.580103,"median":8.972089,"eighty":9.731387,"marketCap":463800243},{"date":"2025-05-09","current":8.40184,"twenty":7.63209,"median":8.956237,"eighty":9.655299,"marketCap":438836491},{"date":"2025-05-16","current":7.799992,"twenty":7.63958,"median":8.89283,"eighty":9.626766,"marketCap":405123785},{"date":"2025-05-23","current":8.575775,"twenty":7.65241,"median":8.850167,"eighty":9.590307,"marketCap":445417178},{"date":"2025-05-30","current":10.26226,"twenty":7.715941,"median":8.87535,"eighty":9.631522,"marketCap":533011510},{"date":"2025-06-06","current":11.248853,"twenty":7.782471,"median":8.89283,"eighty":9.769431,"marketCap":584254194},{"date":"2025-06-13","current":11.425934,"twenty":7.799992,"median":8.956237,"eighty":10.149874,"marketCap":593451599},{"date":"2025-06-20","current":9.494909,"twenty":7.805949,"median":9.034945,"eighty":10.238649,"marketCap":493156089},{"date":"2025-06-27","current":10.742908,"twenty":7.871903,"median":9.097801,"eighty":10.238649,"marketCap":557975894},{"date":"2025-07-03","current":9.697287,"twenty":7.967493,"median":9.217791,"eighty":10.255514,"marketCap":503667409},{"date":"2025-07-11","current":13.188311,"twenty":8.01948,"median":9.285161,"eighty":10.297295,"marketCap":684987676},{"date":"2025-07-18","current":14.385715,"twenty":8.08904,"median":9.384234,"eighty":10.584212,"marketCap":747179651},{"date":"2025-07-25","current":13.871337,"twenty":8.197097,"median":9.417731,"eighty":10.84241,"marketCap":720463380},{"date":"2025-08-01","current":12.437825,"twenty":8.267679,"median":9.479345,"eighty":11.289329,"marketCap":646008198},{"date":"2025-08-08","current":11.231989,"twenty":8.274387,"median":9.503122,"eighty":11.660356,"marketCap":583378251},{"date":"2025-08-15","current":-4.846264,"twenty":8.197097,"median":9.495197,"eighty":11.50014,"marketCap":585409301},{"date":"2025-08-22","current":-4.802702,"twenty":7.843394,"median":9.46183,"eighty":11.412442,"marketCap":580147195},{"date":"2025-08-29","current":-5.180239,"twenty":7.675693,"median":9.408012,"eighty":11.34667,"marketCap":625752114},{"date":"2025-09-05","current":-5.459761,"twenty":7.605258,"median":9.384234,"eighty":11.299448,"marketCap":659517295},{"date":"2025-09-12","current":-9.002797,"twenty":7.051844,"median":9.285161,"eighty":11.248853,"marketCap":1087501923},{"date":"2025-09-19","current":-8.523616,"twenty":6.791906,"median":9.217791,"eighty":11.231989,"marketCap":1029618756},{"date":"2025-09-26","current":-9.565472,"twenty":6.372653,"median":9.072896,"eighty":11.223556,"marketCap":1155470793},{"date":"2025-10-03","current":-9.619925,"twenty":-4.846264,"median":8.956237,"eighty":11.080205,"marketCap":1162048426},{"date":"2025-10-10","current":-10.440341,"twenty":-4.897086,"median":8.912645,"eighty":10.903124,"marketCap":1261151423},{"date":"2025-10-17","current":-10.327806,"twenty":-5.035032,"median":8.87091,"eighty":10.852529,"marketCap":1247557649},{"date":"2025-10-24","current":-10.854179,"twenty":-5.43435,"median":8.743704,"eighty":10.801935,"marketCap":1311141431},{"date":"2025-10-31","current":-12.059392,"twenty":-5.764695,"median":8.710535,"eighty":10.776638,"marketCap":1456726366}],"updateTime":1762069597767},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAZE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576690300","title":"Maze Therapeutics files to sell 9.23M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2576690300","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576690300?lang=en_us&edition=fundamental","pubTime":"2025-10-18 04:20","pubTimestamp":1760732416,"startTime":"0","endTime":"0","summary":"16:17 EDT Maze Therapeutics (MAZE) files to sell 9.23M shares of common stock for holders Published first on TheFly – the ultimate source for real-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-files-to-sell-9-23m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-files-to-sell-9-23m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","BK4007"],"gpt_icon":0},{"id":"2573420993","title":"Maze Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Herve Hoppenot","url":"https://stock-news.laohu8.com/highlight/detail?id=2573420993","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573420993?lang=en_us&edition=fundamental","pubTime":"2025-10-08 04:16","pubTimestamp":1759868195,"startTime":"0","endTime":"0","summary":"Maze Therapeutics Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Herve Hoppenot as the beneficial owner in his capacity as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL3g5FGc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"gpt_icon":0},{"id":"2573671054","title":"Maze Therapeutics appoints Herve Hoppenot as chairman of the board","url":"https://stock-news.laohu8.com/highlight/detail?id=2573671054","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573671054?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:36","pubTimestamp":1759750605,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) announced the appointment of Herve Hoppenot as Chairman of its Board of Directors, succeeding Charles Homcy, M.D., who wil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-appoints-herve-hoppenot-as-chairman-of-the-board-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-appoints-herve-hoppenot-as-chairman-of-the-board-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MAZE"],"gpt_icon":0},{"id":"2573679604","title":"Press Release: Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679604","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679604?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Oct. 06, 2025  -- Maze Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced the appointment of Hervé Hoppenot as Chairman of its Board of Directors, succeeding Charles Homcy, M.D., who will continue to serve on the Board.\"I am honored to assume the role of Chairman of the Board at this pivotal moment for Maze Therapeutics,\" said Mr. Hoppenot. \"With encouraging first-in-human data for MZE782, an oversubscribed $150 million private placement, and important clinical milestones ahead, including the advancement of MZE829 targeting APOL1-mediated kidney disease, Maze is well-positioned to deliver meaningful progress. The team has consistently demonstrated strong execution, and I look forward to working with them to advance therapies that can transform the lives of patients with kidney and metabolic diseases.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TM","03160","BK4099","BK4007","MAZE","BK4555","BK4604","BK4585"],"gpt_icon":0},{"id":"2572550925","title":"Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), I-MAB (IMAB) and Cidara Therapeutics (CDTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572550925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572550925?lang=en_us&edition=fundamental","pubTime":"2025-10-03 18:30","pubTimestamp":1759487445,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Maze Therapeutics, Inc. (MAZE – Research Report), I-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-maze-therapeutics-inc-maze-i-mab-imab-and-cidara-therapeutics-cdtx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-maze-therapeutics-inc-maze-i-mab-imab-and-cidara-therapeutics-cdtx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4535","BK4137","LABU","BK4007","BK4588","BK4585","BK4505","HCSG","MAB","CDTX","XLV","BK4526","IMAB","MAZE","BK4139","BK4581"],"gpt_icon":0},{"id":"2572518700","title":"Analysts’ Top Healthcare Picks: Maze Therapeutics, Inc. (MAZE), Repligen (RGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572518700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572518700?lang=en_us&edition=fundamental","pubTime":"2025-10-02 17:20","pubTimestamp":1759396805,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Maze Therapeutics, Inc. (MAZE – Research Report), Re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-maze-therapeutics-inc-maze-repligen-rgen-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-maze-therapeutics-inc-maze-repligen-rgen-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","LABU","HCSG","BK4581","RGEN","LU1815336091.USD","BK4585","BK4137","XBI","LU0757428866.USD","BK4007","BK4121","BK4588","XLV"],"gpt_icon":0},{"id":"2571713336","title":"Maze Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2571713336","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571713336?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:03","pubTimestamp":1759150980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 29, 2025 09:03 ET (13:03 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2571802635","title":"U.S. RESEARCH ROUNDUP-Amazon, Insulet, Vertex","url":"https://stock-news.laohu8.com/highlight/detail?id=2571802635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571802635?lang=en_us&edition=fundamental","pubTime":"2025-09-29 15:30","pubTimestamp":1759131054,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amazon, Insulet, VertexSept 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, including Amazon, Insulet and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nL5N3VG09V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366192091.USD","LU2065170008.USD","VERX","DTM","WY","SGXZ23171101.USD","AX","LU0310799852.SGD","LU0109391861.USD","XOM","MBX","KBH","BK4532","LU0342679015.USD","BK4534","LU2357305700.SGD","SMG","LU0072462426.USD","LU0238689110.USD","SUPN","CVX","ACAD","FI","LU0965508806.USD","USAW.SI","LU2362541513.USD","LU2028103732.USD","IDA","BK4581","LU1066053197.SGD","LU0289961442.SGD","LU1582987324.SGD","KMX","LU0528227936.USD","AORT","RYN","SNX","IRTC","LU0985320562.USD","PSX","IE0004086264.USD","LU1267930730.SGD","CRNX","LU0889566641.SGD","MAZE","PCH","PODD","HFWA","VMI"],"gpt_icon":1},{"id":"2571089208","title":"Maze Therapeutics Inc : JP Morgan Raises Target Price to $37 From $27","url":"https://stock-news.laohu8.com/highlight/detail?id=2571089208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571089208?lang=en_us&edition=fundamental","pubTime":"2025-09-29 12:30","pubTimestamp":1759120227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VE0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"gpt_icon":0},{"id":"2568762764","title":"Maze Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2568762764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568762764?lang=en_us&edition=fundamental","pubTime":"2025-09-18 18:51","pubTimestamp":1758192660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 18, 2025 06:51 ET (10:51 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2568549614","title":"Two new option listings on September 17th","url":"https://stock-news.laohu8.com/highlight/detail?id=2568549614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568549614?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:30","pubTimestamp":1758112216,"startTime":"0","endTime":"0","summary":"New option listings for September 17th include Maze Therapeutics Inc (MAZE) and WhiteFiber Inc (WYFI). Published first on TheFly – the ultimate sou...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-on-september-17th-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-on-september-17th-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4116","WYFI","BK4007","MAZE"],"gpt_icon":0},{"id":"2567929114","title":"Maze Therapeutics Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2567929114","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567929114?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:50","pubTimestamp":1757940600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 15, 2025 08:50 ET (12:50 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2566975462","title":"Wedbush Boosts Price Target on Maze Therapeutics to $35 From $17, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2566975462","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566975462?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:15","pubTimestamp":1757675720,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) has an average rating of buy and mean price target of $31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAZE"],"gpt_icon":0},{"id":"2566786749","title":"Maze Therapeutics Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2566786749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566786749?lang=en_us&edition=fundamental","pubTime":"2025-09-12 18:07","pubTimestamp":1757671620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 12, 2025 06:07 ET (10:07 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2566928252","title":"Maze Therapeutics Inc : Leerink Partners Raises Target Price to $34 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2566928252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566928252?lang=en_us&edition=fundamental","pubTime":"2025-09-12 14:10","pubTimestamp":1757657455,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UZ01D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MAZE"],"gpt_icon":0},{"id":"2566942226","title":"Maze Therapeutics Advances Clinical Programs Amid Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2566942226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566942226?lang=en_us&edition=fundamental","pubTime":"2025-09-12 11:57","pubTimestamp":1757649438,"startTime":"0","endTime":"0","summary":"Maze Therapeutics, Inc. ( ($MAZE) ) has released its Q2 earnings. Here is a breakdown of the information Maze Therapeutics, Inc. presented to its i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maze-therapeutics-advances-clinical-programs-amid-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maze-therapeutics-advances-clinical-programs-amid-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","BK4007"],"gpt_icon":0},{"id":"2566919453","title":"Maze Therapeutics price target raised to $37 from $30 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2566919453","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566919453?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:05","pubTimestamp":1757621115,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Maze Therapeutics (MAZE) to $37 from $30 and keeps a Buy rating on the shares after the company reported Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-37-from-30-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-37-from-30-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE"],"gpt_icon":0},{"id":"2566919226","title":"Maze Therapeutics price target raised to $34 from $28 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2566919226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566919226?lang=en_us&edition=fundamental","pubTime":"2025-09-12 03:55","pubTimestamp":1757620531,"startTime":"0","endTime":"0","summary":"Leerink analyst Joseph Schwartz raised the firm’s price target on Maze Therapeutics (MAZE) to $34 from $28 and keeps an Outperform rating on the sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-34-from-28-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-34-from-28-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE"],"gpt_icon":0},{"id":"2566629990","title":"BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus","url":"https://stock-news.laohu8.com/highlight/detail?id=2566629990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566629990?lang=en_us&edition=fundamental","pubTime":"2025-09-12 00:19","pubTimestamp":1757607581,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ne","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3N3UY12U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAL","OPEN","LU2168563687.JPY","LU0985320562.USD","ABSI","BTCS","HESM","GEV","SG9999018857.SGD","AMRX","MACW.SI","LU2433249047.HKD","NCLH","IE00BSNM7G36.USD","KR","IE00BKDWB100.SGD","MAZE","UPS","ABBV","GRI","WAY","EXE","CNC","LU0882574055.USD","BK4571","FDX","LU1868836914.USD","LOVE","LU2362541273.HKD","CDW","HLLY","AIRO","CCL","ENVX","LU1917777945.USD","LU0310800379.SGD","ELV","HOFT","IE00BZ199S13.USD","MOH"],"gpt_icon":1},{"id":"2566992068","title":"Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2566992068","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566992068?lang=en_us&edition=fundamental","pubTime":"2025-09-11 23:09","pubTimestamp":1757603340,"startTime":"0","endTime":"0","summary":"U.S. stocks were higher, with the Nasdaq Composite gaining more than 100 points on Thursday.Shares of Maze Therapeutics, Inc. MAZE rose sharply during Thursday's session after the company reported clinical results from its Phase 1 healthy volunteer study of MZE782. The company secured $150 million in oversubscribed private placement.Maze Therapeutics shares jumped 47.7% to $23.67 on Thursday.Here are some other big stocks recording gains in today’s session.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/11/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/11/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/25/09/47623455/maze-therapeutics-opendoor-technologies-oxford-industries-vnet-group-and-other-big-stocks-moving-higher-on-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/09/47623455/maze-therapeutics-opendoor-technologies-oxford-industries-vnet-group-and-other-big-stocks-moving-higher-on-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4531","VNET","MAZE","BK4561","BK4202","LU1046422090.SGD","BK4607","BK4535","BK4562","OXM","BK4007","BK4079","BK4116"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}